INOZYME PHARMA INC

CUSIP: 45790W108 Class: Common Stock

Sofinnova Investments, Inc.'s Holding History (CIK: 0001631134)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 4,280,308 Value ($000) $17,121 Avg Close Range
Q1 2025
Shares 4,280,308 Value ($000) $3,895 Avg Close Range
Q4 2024
Shares 4,280,308 Value ($000) $11,856 Avg Close Range
Q3 2024
Shares 4,280,308 Value ($000) $22,386 Avg Close Range
Q2 2024
Shares 4,280,308 Value ($000) $19,090 Avg Close Range
Q1 2024
Shares 4,280,308 Value ($000) $32,787 Avg Close Range
Q4 2023
Shares 4,280,308 Value ($000) $18,234 Avg Close Range
Q3 2023
Shares 4,280,308 Value ($000) $17,977 Avg Close Range
Q2 2023
Shares 3,655,308 Value ($000) $20,360 Avg Close Range
Q1 2023
Shares 3,655,308 Value ($000) $20,945 Avg Close Range
Q4 2022
Shares 3,655,308 Value ($000) $3,838 Avg Close Range
Q3 2022
Shares 3,655,308 Value ($000) $9,796 Avg Close Range
Q2 2022
Shares 3,655,308 Value ($000) $17,436 Avg Close Range
Q1 2022
Shares 2,028,308 Value ($000) $8,296 Avg Close Range
Q4 2021
Shares 2,028,308 Value ($000) $13,833 Avg Close Range
Q3 2021
Shares 2,028,308 Value ($000) $23,508 Avg Close Range
Q2 2021
Shares 2,028,308 Value ($000) $34,562 Avg Close Range
Q1 2021
Shares 2,028,308 Value ($000) $40,160 Avg Close Range
Q4 2020
Shares 2,028,308 Value ($000) $41,864 Avg Close Range
Q3 2020
Shares 2,028,308 Value ($000) $53,324 Avg Close Range